KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Times Interest Earned (2019 - 2025)

Royalty Pharma's Times Interest Earned history spans 7 years, with the latest figure at $4.12 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 24.98% year-over-year to $4.12; the TTM value through Dec 2025 reached $5.07, down 11.56%, while the annual FY2025 figure was $5.07, 11.56% down from the prior year.
  • Times Interest Earned for Q4 2025 was $4.12 at Royalty Pharma, down from $5.37 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $19.9 in Q2 2021 and bottomed at -$10.28 in Q4 2022.
  • The 5-year median for Times Interest Earned is $5.43 (2025), against an average of $5.78.
  • The largest annual shift saw Times Interest Earned plummeted 414.73% in 2022 before it skyrocketed 590.76% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at $3.27 in 2021, then tumbled by 414.73% to -$10.28 in 2022, then soared by 226.18% to $12.97 in 2023, then plummeted by 57.61% to $5.5 in 2024, then dropped by 24.98% to $4.12 in 2025.
  • Per Business Quant, the three most recent readings for RPRX's Times Interest Earned are $4.12 (Q4 2025), $5.37 (Q3 2025), and $3.06 (Q2 2025).